A Computational Systems Approach to Elucidate New Mechanisms Involved in Progressive Lung Disease

C Norman - 2020 - deepblue.lib.umich.edu
Mucosal surfaces in the lung interface with the outside environment for breathing purposes,
but also provide the first line of defense against invading pathogens. The intricate balance of …

[PDF][PDF] Glycogen synthase kinase-3 (GSK-3) and β-catenin: potential novel therapeutic targets for COPD

W en Natuurwetenschappen, E Sterken, HA Baarsma - Citeseer
The primary objective of this thesis is to establish the functional roles of β-catenin and
glycogen synthase kinase-3 (GSK-3) in the pathological processes that underpin chronic …

Glycogen synthase kinase-3 (GSK-3) and β-catenin

HA Baarsma - core.ac.uk
University of Groningen Glycogen synthase kinase-3 (GSK-3) and β-catenin Baarsma, Hoeke
Abele Page 1 University of Groningen Glycogen synthase kinase-3 (GSK-3) and β-catenin …

Glycogen synthase kinase-3 (GSK-3) in the pathogenesis of pulmonary fibrosis: what we know from the mouse model

F Cinetto - 2015 - research.unipd.it
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by an
aberrant interstitial deposition of collagen in the lung parenchyma, leading to progressive …

[HTML][HTML] Translational Research in Acute Lung Injury and Pulmonary Fibrosis: GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and …

DW Park, S Jiang, Y Liu, GP Siegal, K Inoki… - American Journal of …, 2014 - ncbi.nlm.nih.gov
Although AMP-activated protein kinase (AMPK) is involved in regulating carbohydrate and
lipid metabolism, activated AMPK also plays an anti-inflammatory role in many cell …

Identification of novel therapeutic targets and evaluation of pharmacological treatments in epigenetic and chromatin diseases-the case of Rett syndrome

K Szczesna - 2014 - diposit.ub.edu
[eng] INTRODUCTION: In 1966, Rett syndrome (RTT, OMIM# 312750) was for the first time
described as a clinical issue by Dr. Andreas Rett, an Austrian pediatrician. He has observed …

Avaliação do efeito tipo-antidepressivo da agmatina em um modelo animal de depressão

VB Neis - 2013 - repositorio.ufsc.br
A agmatina é uma amina catiônica endógena cuja ação antidepressiva é reportada em
diversos estudos nos últimos anos. O presente estudo investigou o efeito do tratamento …

[PDF][PDF] GLYCOGEN SYNTHASE KINASE-3 INHIBITION PREVENTS SKELETAL MUSCLE ATROPHY IN AN ANIMAL MODEL OF PULMONARY INFLAMMATION

KJP Verhees - No time to waste: a glycogen synthase kinase3 …, 2013 - researchgate.net
Pulmonary inflammation in acute and chronic disease is often accompanied by skeletal
muscle atrophy. Glycogen synthase kinase‐3 (GSK‐3) has been implicated in the regulation …

Glycogen synthase kinase-3 (GSK-3) and β-catenin: potential novel therapeutic targets for COPD

HA Baarsma - 2012 - research.rug.nl
Chronisch obstructief longlijden of chronic obstructive pulmonary disease (COPD) is een
ziekte die meestal veroorzaakt wordt sigarettenrook. De ziekte wordt gekarakteriseerd door …

Targeting Leukemia Stem Cells in the Hematopoietic Niche

PG Miller - 2011 - search.proquest.com
Leukemia is a clonal neoplastic disorder that results from the acquisition of genetic lesions
in hematopoietic stem and progenitor cells (HSPCs). Leukemia stem cells (LSCs), a …